肠道微生物群及其代谢产物对代谢相关性脂肪肝进展的影响

Q2 Medicine
Yuan-Yuan Wang, Hai-Lian Lin, Ke-Lang Wang, Gen-Xiang Que, Ting Cao, La-Mei Zhu, Xia Yang, Xue-Feng Yang
{"title":"肠道微生物群及其代谢产物对代谢相关性脂肪肝进展的影响","authors":"Yuan-Yuan Wang, Hai-Lian Lin, Ke-Lang Wang, Gen-Xiang Que, Ting Cao, La-Mei Zhu, Xia Yang, Xue-Feng Yang","doi":"10.24920/004220","DOIUrl":null,"url":null,"abstract":"<p><p>Metabolic associated fatty liver disease (MAFLD) has become a prevalent chronic liver disease worldwide because of lifestyle and dietary changes. Gut microbiota and its metabolites have been shown to play a critical role in the pathogenesis of MAFLD. Understanding of the function of gut microbiota and its metabolites in MAFLD may help to elucidate pathological mechanisms, identify diagnostic markers, and develop drugs or probiotics for the treatment of MAFLD. Here we review the pathogenesis of MAFLD by gut microbiota and its metabolites and discuss the feasibility of treating MAFLD from the perspective of gut microbes.</p>","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":" ","pages":"286-296"},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Influence of Gut Microbiota and its Metabolites on Progression of Metabolic Associated Fatty Liver Disease.\",\"authors\":\"Yuan-Yuan Wang, Hai-Lian Lin, Ke-Lang Wang, Gen-Xiang Que, Ting Cao, La-Mei Zhu, Xia Yang, Xue-Feng Yang\",\"doi\":\"10.24920/004220\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Metabolic associated fatty liver disease (MAFLD) has become a prevalent chronic liver disease worldwide because of lifestyle and dietary changes. Gut microbiota and its metabolites have been shown to play a critical role in the pathogenesis of MAFLD. Understanding of the function of gut microbiota and its metabolites in MAFLD may help to elucidate pathological mechanisms, identify diagnostic markers, and develop drugs or probiotics for the treatment of MAFLD. Here we review the pathogenesis of MAFLD by gut microbiota and its metabolites and discuss the feasibility of treating MAFLD from the perspective of gut microbes.</p>\",\"PeriodicalId\":35615,\"journal\":{\"name\":\"Chinese Medical Sciences Journal\",\"volume\":\" \",\"pages\":\"286-296\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chinese Medical Sciences Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.24920/004220\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Medical Sciences Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.24920/004220","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

由于生活方式和饮食习惯的改变,代谢相关性脂肪肝(MAFLD)已成为全球流行的慢性肝病。肠道微生物群及其代谢产物已被证明在代谢相关性脂肪肝的发病机制中起着至关重要的作用。了解肠道微生物群及其代谢产物在 MAFLD 中的功能有助于阐明病理机制、确定诊断标志物以及开发治疗 MAFLD 的药物或益生菌。在此,我们回顾了肠道微生物群及其代谢产物对 MAFLD 的致病机理,并从肠道微生物的角度探讨了治疗 MAFLD 的可行性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Influence of Gut Microbiota and its Metabolites on Progression of Metabolic Associated Fatty Liver Disease.

Metabolic associated fatty liver disease (MAFLD) has become a prevalent chronic liver disease worldwide because of lifestyle and dietary changes. Gut microbiota and its metabolites have been shown to play a critical role in the pathogenesis of MAFLD. Understanding of the function of gut microbiota and its metabolites in MAFLD may help to elucidate pathological mechanisms, identify diagnostic markers, and develop drugs or probiotics for the treatment of MAFLD. Here we review the pathogenesis of MAFLD by gut microbiota and its metabolites and discuss the feasibility of treating MAFLD from the perspective of gut microbes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Chinese Medical Sciences Journal
Chinese Medical Sciences Journal Medicine-Medicine (all)
CiteScore
2.40
自引率
0.00%
发文量
1275
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信